Hitting a stretch where the scale won’t budge is one of the most common frustrations reported by people using GLP-1 medications like semaglutide for weight management. If you’ve been consistent with your regimen and the number on the scale has stalled, it doesn’t necessarily mean the medication has “stopped working” — plateaus are a well-documented part of the weight loss process, on GLP-1 therapy and otherwise.
Why plateaus happen
According to research summarized by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), weight loss plateaus occur in part because the body adapts metabolically as weight decreases — resting energy expenditure tends to drop along with body mass, meaning the same calorie intake and activity level that produced a deficit earlier may no longer produce one later. This is a physiological response, not a sign of personal failure or that the medication has become ineffective.
The Mayo Clinic and clinical trial data published in outlets indexed by the National Library of Medicine also note that individual response to GLP-1 medications varies considerably, and weight loss on these medications often follows a curve — more rapid in the initial months, then gradually leveling off — rather than a straight line.
Factors that may be worth examining
Some considerations that clinicians commonly discuss with patients experiencing a plateau include:
- Protein and fiber intake — adequate protein can help preserve lean muscle mass during weight loss, which in turn affects metabolic rate.
- Sleep quality and stress — both are linked in research to hormonal factors (like cortisol and ghrelin) that can influence appetite and weight regulation.
- Resistance training — the CDC’s physical activity guidelines highlight strength training as a component that supports metabolic health during weight loss, alongside cardiovascular activity.
- Time on current dose — some people plateau at a given dose and see continued progress after their prescriber evaluates whether a change is appropriate for them specifically.
What not to do on your own
It’s important to be direct about this: dose changes, switching medications (for example between semaglutide and other GLP-1/GIP agents), or extending/shortening your regimen should only be done under your prescribing clinician’s guidance. Self-adjusting dosing is not something this article — or any general health content — can responsibly advise on, since the right approach depends on your individual medical history, labs, and response.
If you’ve plateaued, the most useful next step is typically a check-in with your prescriber rather than troubleshooting alone. They can assess whether your current plan still fits your goals, review any side effects, and determine whether adjustments make sense for your specific case.
This article is for general educational purposes only and does not constitute medical advice. Do not adjust your dose or medication regimen without consulting your prescribing healthcare provider.
— Gemifys
